INDACO VENTURE PARTNERS INVESTS IN SERIES B OF GENESPIRE
Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into
INDACO VENTURE PARTNERS SEEDS MICROBIAL DERIVED ONCOLOGY THERAPEUTICS COMPANY, MICTHERA
Milan, May 30th 2024 – Indaco Venture Partners is pleased to announce its first technology transfer investment into MicThera
INDACO VENTURE PARTNERS – NOUSCOM RAISES €67.5 MILLION ($72 MILLION) IN OVERSUBSCRIBED SERIES C FINANCING ROUND
Milano, 14 November 2023 – Indaco Venture Partners SGR, one of the largest independent Italian venture capital asset management
INDACO VENTURE PARTNERS – FREYA BIOSCIENCES RAISES USD 38 MILLION IN A SERIES A TO ADVANCE GROUND BREAKING IMMUNOTHERAPY PLATFORM TARGETING VAGINAL MICROBIOTA
Milano, 12 December 2023 – Indaco Venture Partners SGR, one of the largest independent Italian venture capital asset management company
INDACO VENTURE PARTNERS – HOBA THERAPEUTICS RAISES EUR 23 MILLION IN A SERIES A TO ADVANCE NEW DRUG CANDIDATE AGAINST CHORNIC NEUROPATHIC PAIN
Milano, 11 December 2023 – Indaco Venture Partners SGR, one of the largest independent Italian venture capital asset management company
Indaco Bio Fund investe in Alia Therapeutics
Nuovo round di 4,4 milioni di euro che permetterà di accelerare lo sviluppo di terapie innovative basate su CRISPR MILANO, 17
INDACO VENTURE PARTNERS – PRIMO INVESTIMENTO DEL FONDO INDACO BIO NEL ROUND DI FINANZIAMENTO DI 23 MILIONI DI EURO IN SIBYLLA BIOTECH
Milano, 4 ottobre 2022 – Indaco Venture Partners SGR, uno dei principali operatori indipendenti italiani di venture capital, annuncia oggi